Longeveron Inc.

$LGVN is surging today and leading the Prism MarketView Public Health index today. The FDA has granted Regenerative Medicine Advanced Therapy designation to the company’s Lomecel-B treatment.

Share This Article

 

About the Author

Longeveron Inc.

Joey Ramson